Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-27

Clinical Trial Update: Heartland Osteoporosis Prevention Study [Phase 3]

View source ↗

Summary

Phase 3 trial completion for Heartland Osteoporosis Prevention Study in osteopenia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Osteopenia | Phase 3 | Status: COMPLETED | Results posted: 2023-06-27